Highland Park, NJ, United States of America

Xiao Yan Qian

This inventor holds 1 USPTO granted patent. Top assignee: Rutgers, The State University of New Jersey. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiao Yan Qian. Retrieved from https://idiyas.com/inventor/xiao-yan-qian

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Xiao Yan Qian in HIV Research.

Introduction

Xiao Yan Qian is a notable inventor based in Highland Park, NJ (US). She has made significant contributions to the field of HIV research through her innovative work. Her research focuses on developing novel approaches to inhibit HIV-1 expression, which is crucial for advancing treatment options.

Latest Patents

Xiao Yan Qian holds a patent for "Chimeric nucleic acids and proteins for inhibiting HIV-1 expression." This patent describes a chimeric nucleic acid molecule that encodes an NS1-Rev fusion protein with Rev function inhibitory activity. This innovative approach has the potential to impact the treatment of HIV significantly.

Career Highlights

Xiao Yan Qian is affiliated with Rutgers, The State University of New Jersey, where she continues her research and development efforts. Her work has garnered attention in the scientific community, highlighting her dedication to advancing medical science.

Collaborations

Xiao Yan Qian collaborates with Robert M. Krug, a fellow researcher in the field. Their combined expertise enhances the potential for groundbreaking discoveries in HIV research.

Conclusion

Xiao Yan Qian's contributions to HIV research through her innovative patents and collaborations underscore her importance in the scientific community. Her work continues to pave the way for advancements in treatment and understanding of HIV.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…